Editorial: Silent but Detectable—High Throughput Proteomics to Identify Clinically Significant Liver Disease. Authors' Reply

Alimentary Pharmacology & Therapeutics, vol. 64, pp. 273–274

Authors 2

1. Katharina Remih Aachen Medical Clinic III

   RWTH Aachen University · Universitätsklinikum Aachen

   Affiliation as printed

   Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER) Aachen Germany

2. Pavel Strnad corresponding Aachen Medical Clinic III

   RWTH Aachen University · Universitätsklinikum Aachen · Medizinische Universität Lausitz - Carl Thiem

   Affiliation as printed

   Department of Gastroenterology and Hepatology Medical University Lausitz ‐ Carl‐Thiem Cottbus Germany

   Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER) Aachen Germany